Abcam establishes direct service for ANZ
Protein research tool provider Abcam has established a direct service to Australia and New Zealand. Researchers can now source products and technical support directly from the UK-based company, rather than through distributors, which is expected to improve delivery times and better meet researchers’ needs.
“I’m delighted that we can offer an enhanced service to our customers in Australia and New Zealand,” said Abcam Commercial Director Philippe Cotrel.
Abcam’s in-house manufacturing facilities provide researchers with high-performance products such as primary and secondary antibodies, biochemicals, proteins, peptides, lysates and immunoassays. In addition, the company offers technical support and up-to-date datasheets.
“A direct service will enable us to develop closer relationships with our customers and ensure we are fully meeting their research needs,” said Cotrel.
Review of R&D system a highlight of the 2024–25 Budget
Australia's science bodies have been broadly positive about the 2024–25 federal Budget...
ACRF funds three new cancer research facilities
Scientists at QIMR Berghofer, the Peter MacCallum Cancer Centre and the Bio21 Institute have...
Govt announces $1.89bn package for health and medical research
The Australian Government is investing in a "once-in-a-generation transformation of health...